Ensuring trial validity by data quality assurance and diversification of monitoring methods

Clinical Trials

Volumn 5, Issue 1, 2008, Pages 49-55

  Baigent, Colin ^a   Harrell, Frank E ^b   Buyse, Marc ^c   Emberson, Jonathan R ^a   Altman, Douglas G ^d  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; COMPARATIVE STUDY; CONFERENCE PAPER; INFORMATION PROCESSING; METHODOLOGY; MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; QUALITY CONTROL; RISK ASSESSMENT; SAMPLE SIZE; TAXONOMY; VALIDITY;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS DATA MONITORING COMMITTEES; HUMANS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 40949130893     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774507087554     Document Type: Conference Paper

References (10)

1. Altman DG, Bland JM. Absence of evidence is not evidence of absence. Br Med J 1995; 311: 485.
2. Sterne JAC, Davey Smith G. Sifting the evidence - what's wrong with significance tests? Br Med J 2001; 322: 226-31.
3. The DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them do their job well. Lancet 2005; 365: 711-22.
4. Grant AM, Sydes M, McLeer S, et al. Issues in data monitoring and interim analysis of trials (the DAMOCLES study). Health Technol Assess 2005; 9: 1-238.
5. Buyse M, George SL, Evans S, et al. for the ISCB Subcommittee on Fraud. Statist Med 1999; 18: 3435-51.
6. Ellenberg SS, Fleming TR, DeMets DL. Data Monitoring Committees in Clinical Trials. A Practical Perspective John Wiley, London, 2002.
7. MRC/DH joint project to codify good practice in publicly-funded UK clinical trials with medicines. Workstream 4: Trial Management and Monitoring (http://www.ct-toolkit.ac.uk/_db/_documents/trial_MP.pdf (accessed 4th April 2007).
8. Al-Marzouki S, Evans S, Marshall T, et al.Are these data real? Statistical methods for detection of data fabrication in clinical trials. Br Med J 2005; 331: 267-70.
9. The ESPS2 Group. European Stroke Prevention Study 2. Efficacy and safety data. J Neurol Sciences 1997 (Suppl); 151: S1-S77.
10. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guidelines. Guideline for good clinical practice E6. http://www. ich.org/LOB/media/MEDIA482.pdf (accessed 26th April 2007).